Data / Form D filings / GevRx Nutraceuticals, Inc.
GevRx Nutraceuticals, Inc.: Form D filing
GevRx Nutraceuticals, Inc., a biotechnology company in Staten Island, NY, filed a Form D with the SEC in 2026. The latest, on September 18, 2026, reports $300,000 sold of a $3 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 20 MARBLE LOOP SUITE 2A, Staten Island, NY, 10309
- Phone
- (917) 939-9424
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2026
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2156105
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | New notice | $3,000,000 | $300,000 | $2,700,000 | 1 | Sep 11, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| James Thomas Christopher | Executive Officer, Director | President, Secretary and Treasurer |
| Douglas Spiel, M.D. | Executive Officer, Director | Chief Executive Officer and Chief Medical Director |
| Mary Stephen Esposito | Director | |
| Dylan Tyler Spiel | Executive Officer | Vice President |
| Michael J. Betley, Ph.D. | Executive Officer | Chief Scientific Officer |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Sep 14, 2026 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what GevRx Nutraceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.